1. Introduction to special issue

   • Roberta Glick

   Introductory Pages: 1 - 1

2. Brain tumor immunotherapy: an immunologist’s perspective

   • Lois A. Lampson

   Introductory Pages: 3 - 11

3. Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy

   • Hideho Okada
   • Frank S. Lieberman
   • Ian F. Pollack

   Tumor Immunology: Steps And Principles Pages: 13 - 20

4. MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor

   • Howard Broder
   • Andrea Anderson
   • Linda M. Liau

   Tumor Immunology: Steps And Principles Pages: 21 - 30

5. Robust ability of IFN-γ to upregulate class II MHC antigen expression in tumor bearing rat brains

   • Tanya Dutta
   • Alexander Spence
   • Lois A. Lampson

   Tumor Immunology: Steps And Principles Pages: 31 - 44

6. Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression

   • Robert M. Prins
   • Martin R. Graf
   • Christopher J. Wheeler

   Tumor Immunology: Steps And Principles Pages: 45 - 54

7. Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium

   • John S. Yu
   • Paul K. Lee
   • Christopher J. Wheeler

   Tumor Immunology: Steps And Principles Pages: 55 - 61

8. Expression of a soluble transforming growth factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcomain vivo

   • Timothy F. Witham
   • Lorissa Villa
   • William H. Chambers

   Tumor Immunology: Steps And Principles Pages: 63 - 69

9. Survivin in brain tumors: an attractive target for immunotherapy

   • Masahito Katoh
   • Rick Wilmotte
   • Pierre-Yves Dietrich

   Tumor Antigens: Twists And Turns Pages: 71 - 76

10. Autologous adjuvant linked fibroblasts induce anti-glioma immunity: implications for development of a glioma vaccine

    • Andrew T. Parsa
    • John I. Miller
    • Jeffrey N. Bruce

    Tumor Antigens: Twists And Turns Pages: 77 - 87

11. γ Interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes

    • David B. Paul
    • Susana B. Read
    • Carol A. Kruse

    Tumor Antigens: Twists And Turns Pages: 89 - 99

12. Immunotoxin therapy for CNS tumor

    • Edward Rustamzadeh
    • Walter C. Low
    • Walter A. Hall

    Tumor Antigens: Twists And Turns Pages: 101 - 116

13. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor α2-expressing glioma

    • Akiva Mintz
    • Denise M. Gibo
    • Waldemar Debinski

    Tumor Antigens: Twists And Turns Pages: 117 - 123

14. Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma

    • Friedrich Weber
    • Anthony Asher
    • Raj K. Puri

    Tumor Antigens: Twists And Turns Pages: 125 - 137

15. Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors

    • Roberta P. Glick
    • Terry Lichtor
    • Edward P. Cohen

    Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 139 - 146

16. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene — a phase I/II clinical protocol

    • H. Ren
    • T. Boulikas
    • N. G. Rainov

    Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 147 - 154

17. Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2

    • Maciej S. Lesniak
    • Betty M. Tyler
    • Henry Brem

    Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 155 - 160

18. The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors

    • Peter E. Fecci
    • Duane A. Mitchell
    • John H. Sampson

    Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 161 - 176

19. Human autologous dendritic cell-glioma fusions: feasibility and capacity to stimulate T cells with proliferative and cytolytic activity

    • Andrew E. Sloan
    • Prahlad Parajuli

    Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 177 - 183

20. Calendar

    Events Pages: 185 - 186